The role of gut-derived factors in provoking rheumatic disease was first proposed by Rea Smith in 1922.1 Since then the link between inflammatory bowel disease and arthritis has become firmly established,2 and antigens derived from the gut have been implicated in the pathogenesis of several rheumatic disorders, including reactive arthritis, ankylosing spondylitis, and even rheumatoid arthritis. 3 Coeliac disease (gluten-sensitive enteropathy) is known to be associated with abnormal intestinal permeability. 4 (Fig. 3 ).
Of the initial six patients (Table 1) four were female and two male. Age at diagnosis of coeliac disease ranged from 20 to 60 years (mean 39-3 years).
Duration of symptoms (Table 1) . Joint pain preceded diagnosis by up to three years in five patients and by 15 years in one patient. In three cases there were no bowel symptoms, the diagnosis being suspected because of associated anaemia.
Pattern ofjoint involvement (Fig. 4) . The distribution of arthritis varied widely. Lumbar spine, hip, knee, and shoulder were affected most commonly.
Pain at rest (six patients), morning stiffness of more than 30 min (four patients), symptomatic flares (five patients), and joint swelling (two patients) were prominent symptoms. Painful limitation of move- ment (five patients) and joint tenderness (four patients) were the commonest physical signs.
Other prominent clinical features. Five patients complained of malaise and weight loss. Proximal myopathy was noted in two cases.
Laboratory data ( Table 2) . Useful screening tests included evidence of anaemia (five patients), macrocytosis (four patients), and low serum folate (all six patients). ESR was clearly raised in two patients and marginally raised in a further three patients. Biochemical evidence for coexisting osteomalacia was found in three patients (Nos 2, 4, and 6).
All were latex negative and had normal immunoglobulins.
X-ray changes. X-rays were normal in four patients. One patient showed congenital fusion of (Table 3) . HLA-type Al, B8, DR3 was present in five patients. HLA-B27 was found in two patients, neither of whom had clinical evidence of ankylosing spondylitis. X-ray evidence of sacroiliitis (asymptomatic) was present in one of these.
Outcome. All patients were placed on a glutenfree diet after demonstration of coeliac disease by jejunal biopsy. Three patients experienced complete and lasting remission of their arthritis within three months. Two patients noted marked improvement over a similar time period but continue to experience residual joint symptoms. A further patient noted moderate improvement only.
Gluten challenge. Three patients agreed to undergo gluten challenge for the purposes of: (a) confirming the diagnosis of coeliac disease; and (b) observing the effect of a normal diet on the course of their arthritis. Each patient received a normal diet plus 20 g additional gluten per day. Jejunal biopsies after three weeks in patients No 1 and 5 and after one week in patient No 3 all showed relapse, confirming the diagnosis of coeliac disease. No patient experienced a return of joint symptoms over this period. A fourth patient (No 4) reported exacerbation of pain and swelling in his left knee 24 hours after lapsing from his gluten-free diet, though this episode was not witnessed by us. The age range of the 160 treated coeliac patients examined was 15 to 81 years (mean 46.5 years), female to male ratio 3-3:1, and time from diagnosis one month to 67 years (mean 11*4 years). The distribution of locomotor disease is shown in Table  4 . Evidence of synovitis for which no clear diagnosis could be made ('undifferentiated arthritis', Table 4) was found in six patients. The small joints of the hands and wrists were affected most commonly and symptoms in all subjects settled within three years of onset. This arthritis was not thought to be attributable to coeliac disease. No specific arthritis was identified and there was no evidence of ankylosing spondylitis.
The age range of the 100 patients with Crohn's disease examined was similar: 16 to 82 years (mean 38-3 years), female to male ratio 2:1, and time from diagnosis five months to 35 years (mean 9-1 years). The distribution of locomotor symptoms is shown in Table 5 . Seronegative polyarthritis was found in 23% and ankylosing spondylitis in 5% (p<0-01).
Discussion
Well recognised musculoskeletal manifestations of coeliac disease (CD) include metabolic bone dis- circulating immune complexes in the majority of our patients, but the levels do not correlate well with the onset of arthritis. The failure to provoke arthritis after gluten challenge despite relapse of jejunal mucosa suggests that gluten or its constituents are not directly responsible for promoting arthritis. We have not excluded this possibility, however, since the bowel may relapse more quickly than the joints. It was considered unethical to extend the period of gluten challenge beyond three weeks.
We postulate that abnormal mucosal permeability in untreated coeliac disease allows access to as yet unidentified provoking antigens which may vary widely between individuals. This would account for the varied clinical picture and the absence of coeliac-related arthritis in the treated population. We have not investigated the incidence of arthritis amongst untreated coeliacs. The lengthy time period over which our six patients were identified suggests that the incidence amongst this population is very low. This implies that altered intestinal permeability is only one of several factors leading to arthritis. A better understanding of the mechanism of this rare form of arthritis may provide important clues to the wider role of gastrointestinal antigens and genetic susceptibility in rheumatic disease. 
